ARCHIVES

Study Opens For Women At Risk of Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

Zerhouni Starts Work As NIH Director

May 24, 2002

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

IVAX And It’s Portfolio

December 22, 1994

Dana-Farber, Harvard And Affiliates Form Cancer Center.

February 4, 2000